SignatureFD’s Vir Biotechnology VIR Stock Holding History

SignatureFD’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.49K	Buy	948 +250	+36%	+$1.99K	﹤0.01%	2574
2025 Q4	$4.21K	Sell	698 -82	-11%	-$488	﹤0.01%	2752
2025 Q3	$4.45K	Buy	780 +206	+36%	+$1.05K	﹤0.01%	2722
2025 Q2	$2.89K	Buy	+574	New	+$3.08K	﹤0.01%	2769
2025 Q1	–	Sell	-179	Closed	-$1.31K	–	3466
2024 Q4	$1.31K	Sell	179 -406	-69%	-$3.2K	﹤0.01%	2980
2024 Q3	$4.38K	Sell	585 -2,539	-81%	-$22.1K	﹤0.01%	2615
2024 Q2	$27.8K	Buy	3,124 +24	+0.8%	+$230	﹤0.01%	1806
2024 Q1	$31.4K	Sell	3,100 -227	-7%	-$2.31K	﹤0.01%	1776
2023 Q4	$33.5K	Buy	3,327 +2,399	+259%	+$21.9K	﹤0.01%	1664
2023 Q3	$8.7K	Buy	928 +869	+1,473%	+$12.4K	﹤0.01%	2284
2023 Q2	$1.45K	Sell	59 -1,241	-95%	-$31.2K	﹤0.01%	2887
2023 Q1	$30.3K	Buy	1,300 +1,208	+1,313%	+$30.9K	﹤0.01%	1644
2022 Q4	$2.33K	Sell	92 -74	-45%	-$1.81K	﹤0.01%	2756
2022 Q3	$3K	Buy	166 +8	+5%	+$203	﹤0.01%	2700
2022 Q2	$4K	Buy	158 +74	+88%	+$1.73K	﹤0.01%	2559
2022 Q1	$2K	Sell	84 -91	-52%	-$2.7K	﹤0.01%	2871
2021 Q4	$7K	Buy	175 +62	+55%	+$2.43K	﹤0.01%	2300
2021 Q3	$5K	Buy	113 +26	+30%	+$1.13K	﹤0.01%	2376
2021 Q2	$4K	Buy	+87	New	+$3.96K	﹤0.01%	2388

Other funds holding VIR

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

GSK plc London $599M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return